Complete remission of multiple myeloma associated IgA pemphigus after therapy with bortezomib (Velcade), cyclophosphamide and dexamethasone: Case report

被引：0
|
作者：
Szturz, P. [1 ,2 ]
Adam, Z. [1 ,2 ]
Feit, J. [1 ,3 ]
Krejci, M. [1 ,2 ]
Pour, L. [1 ,2 ]
Vasku, V. [1 ,4 ]
Cermakova, Z. [5 ]
Hajek, R. [1 ,2 ]
Mayer, J. [1 ,2 ]
机构：
[1] Masaryk Univ, Fac Med, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematooncol, Brno, Czech Republic
[3] Univ Hosp Brno, Inst Pathol, Brno, Czech Republic
[4] St Annes Univ Hosp Brno, Dept Dermatol & Venereol 1, Brno, Czech Republic
[5] Univ Hosp Brno, Dept Clin Biochem & Hematol, Brno, Czech Republic
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [21] Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Sauer, Sandra
    Kriegsmann, Katharina
    Nientiedt, Cathleen
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Raab, Marc-Steffen
    Kauer, Joseph
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05) : 371 - 380
  • [22] A Case of Multiple Pulmonary Plasmacytomas after Complete Remission of Multiple Myeloma
    Sung, Pil Soo
    Song, Joon Ho
    Park, Chong Won
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2010, 69 (02) : 129 - 133
  • [23] Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Dib, M.
    Caillot, D.
    Niederwieser, D.
    Masszi, T.
    Fontan, J.
    Michallet, M.
    Gratwohl, A.
    Milone, G.
    Doyen, C.
    Pegourie, B.
    Hajek, R.
    Casassus, P.
    Kolb, B.
    Chaleteix, C.
    Hertenstein, B.
    Onida, F.
    Ludwig, H.
    Vekemans, M. C.
    Ketterer, N.
    Daguenel, A.
    Koenecke, C.
    Gorin, N. -C.
    Harousseau, J. -L.
    de Witte, T.
    Morris, C.
    Gahrton, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S3 - S3
  • [24] The rapid resolution of pseudohyperphosphatemia in an IGAκ multiple myeloma patient after therapy with a bortezomib-containing regimen: Report of the first case
    Maden, Muhammet
    Pamuk, Gulsum Emel
    Asoglu, Veysi
    Pamuk, Omer Nuri
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04)
  • [25] Thalidomide/dexamethasone (TD), bortezomib (Velcade)/thalidomide/dexamethasone (VTD) and VBMCP/VBAD/Velcade as induction therapy prior to high-dose therapy/autologous stem cell transplantation in multiple myeloma
    Rosinol, L.
    Cibeira, M. T.
    Martinez, J.
    Mateos, M. V.
    Oriol, A.
    Terol, M. J.
    Garcia-Larana, J.
    Hernandez, D.
    de la Rubia, J.
    Sureda, A.
    Besalduch, J.
    Palomera, L.
    Gonzalez, Y.
    Echebeste, M. A.
    Diaz-Mediavilla, J.
    de Arriba, F.
    Alegre, A.
    Hernandez, M.
    Lahuerta, J. J.
    Miguel, J. F. San
    Blade, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S18 - S18
  • [26] Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient
    M Engelhardt
    A M S Müller
    W Maier
    R Wäsch
    Leukemia, 2005, 19 : 869 - 870
  • [27] Bortezomib-thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    Moreau, Philippe
    Mary, Jean-Yves
    Attal, Michel
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 605 - 606
  • [28] Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient
    Engelhardt, M
    Müller, AMS
    Maier, W
    Wäsch, R
    LEUKEMIA, 2005, 19 (05) : 869 - 870
  • [29] Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone
    Lan Xialu
    Zhang Fujing
    Yang Chen
    Su Wei
    Du Jianhua
    Liu Shuangjiao
    Chen Miao
    Han Bing
    Zhou Daobin
    Zhuang Junling
    慢性疾病与转化医学（英文）, 2024, 10 (01)
  • [30] Treatment With Elotuzumab in Combination With Dexamethasone Achieves a Complete Remission in a Previously Treated Patient With Multiple Myeloma: A Case Report
    Meyers, Sydney
    Henning, Chace
    Swift, Regina
    Eades, Benjamin
    Spektor, Tanya M.
    Berenson, James R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11): : E801 - E804
12345